In this episode Venkat Sethuraman, SVP Global Biometrics and Data Science, Bristol-Myers Squibb talks with Tom Lehmann about the critical role of data, design and digital in the future vision for R&D.

Host Tom Lehmann talks with Craig Lipset, a long-time advocate and inspiring innovator in the clinical research and medicine development community. Drawing on his role as co-convenor of the Decentralized Trials and Research Alliance (DTRA), a collaboration of over 120 member organizations, Craig discusses DTRA's ambitions and priorities for bringing greater accessibility to clinical trials and making decentralized clinical research methods the standard for the industry.

Tom Lehmann talks with Frances Taheri, Accenture Ventures Digital Health Lead, about the need for companies to enable their ecosystems to collaborate freely without compromising data security and privacy in the conclusion of our Life Sciences Tech Trends series.

Tom Lehmann talks again with David Hole about the "bring your own environment" (BYOE) model that will drive the industry's technology agenda in terms of connectivity, collaboration and the tools that enable them in part four of our Life Sciences Tech Trends series.

Tom Lehmann talks with David Hole, Accenture Life Sciences Talent and Organization Lead, about making technology accessible to all to put powerful capabilities in the hands of people across functions in part three of our Life Sciences Tech Trends series.

Tom Lehmann talks with Andy Greenberg, Accenture North America Digital Health Lead, about the therapeutic potential of massive, intelligent, digital twins in part two of our Life Sciences Tech Trends series.

Host Tom Lehmann begins this special series centered on the 2021 Life Sciences Technology Vision with Shalu Chadha, Accenture Life Sciences Technology Lead, about architecting a better future with technology stacks that are fluid across the ecosystem.

Host Tom Lehmann talks with John Kelleher, head of digital quality for Pfizer global supply. John shares insights on connecting learnings and impacts of a digital QA transformation pilot to a more holistic QC transformation initiative.

Debraj Dasgupta talks with Tom Lehmann about the building blocks and historic obstacles to a successful digital transformation in biopharma.

Tom Lehmann discusses tapping into digital to achieve greater patient-centricity with Jen Spada and Tina Ripperger.